GlassScriptPhysician profile
Emily Flagler
NPI 1598329831
$952.71
in general payments reported to CMS, 2019-2025
19 companies · $465 in 2025
The $465 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $137 · 2024: $351 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.72 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $243.61 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $104.50 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $97.42 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $77.44 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $71.76 | 2023-2025 | |
| Dexcom, INC. | $64.94 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $55.59 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Supernus Pharmaceuticals, INC. | $23.93 | 2025 | Qelbree |
| Pacira Pharmaceuticals Incorporated | $23.68 | 2023 | Exparel |
| Convatec INC. | $23.06 | 2023 | |
| Baxter Healthcare | $22.94 | 2024 | Perclot |
| Medtronic, INC. | $21.98 | 2023 | Ligasure |
| Daiichi Sankyo INC. | $20.26 | 2024 | Injectafer |
| Minerva Surgical, INC | $19.22 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $19.10 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.78 | 2025 | Aptima |
| Aspira Women'S Health INC | $16.86 | 2024 | Ova1 |
| Organon LLC | $15.03 | 2023 | Nexplanon |
| Pfizer INC. | $13.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Flagler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.